The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,984.00
Bid: 1,984.00
Ask: 1,986.00
Change: -10.00 (-0.50%)
Spread: 2.00 (0.101%)
Open: 1,991.00
High: 2,004.00
Low: 1,977.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 17th Jul 2014 11:07

Antofagasta: Canaccord Genuity cuts target price from 870p to 835p and maintains a hold recommendation.African Minerals: Canaccord Genuity reduces target price from 230p to 170p and keeps a buy recommendation.Ashmore Group: Goldman Sachs downgrades to neutral with a target price of 430p.Barclays: Exane reduces target price from 280p to 225p retaining a neutral rating.BHP Billiton: Goldman Sachs lowers target price from 1820p to 1810p retaining its neutral rating. Canaccord Genuity reduces target price from 2100p to 1935p and keeps a hold recommendation.Big Yellow Group: Morgan Stanley raises target price from 445p to 615p and upgrades from equal-weight to overweight.Central Asia Mining: Canaccord Genuity lowers target price from 200p to 190p retaining its buy recommendation.City of London Investment Group: N+1 Singer raises target price from 220p to 317p and upgrades to buy.Croda International: Barclays reduces target price from 2330p to 2100p and downgrades from equal-weight to underweight.Diageo: JP Morgan cuts target price from 1780p to 1760p and downgrades from neutral to underweight.Drax Group: Citi cuts target price from 750p to 700p downgrading from buy to neutral.EMIS: Panmure Gordon moves target price from 851p to 858p keeping a buy recommendation. N+1 Singer moves target price from 820p to 830p and retains a buy recommendation.International Ferro Metal: Numis places both its target price and its buy recommendation under review.Fesnillo: Deutsche Bank takes target price from 870p to 890p and maintains a hold recommendation. JP Morgan ups target price from 1030p to 1100p and retains an overweight rating.Friends Life Group: Berenberg ups target price from 310p to 330p and keeps a hold recommendation.Gable Holdings: Panmure Gordon moves target from 92p to 105p and retains a buy recommendation.Genel Energy: Canaccord Genuity reduces target price from 1230p to 1100p, while its buy recommendation remains kept.Glencore Xstrata: Goldman Sachs shifts target price from 295p to 300p and stays with its neutral rating.Greene King: JP Morgan reduces target price from 940p to 890p leaving its neutral rating unaltered.Gulf Keystone: Canaccord Genuity shifts target price from 95p to 100p and keeps a hold recommendation.Hikma Pharmaceuticals: UBS raises target price from 1700p to 2000p and upgrades from neutral to buy.Hilton Food Group: Numis cuts target price from 610p to 592p and retains an add rating.ICAP: UBS lowers target price from 330p to 320p and keeps a sell recommendation. Citi cuts target price from 385p to 370p and leaves its neutral rating unchanged.ITV: Investec places both its target price (prev.: 195p) and its hold recommendation under review.Judges Scientific: WH Ireland reduces target price from 2370p to 1550p and stays with its neutral rating.Kazakhmys: Canaccord Genuity shifts target price from 260p to 265p, while downgrading from hold to sell.Lancashire: JP Morgan cuts target price from 744p to 725p and stays with its neutral rating.Oxford Instruments: N+1 Singer reduces target price from 1445p to 1350p and maintains a hold recommendation.Phoenix Group Holdings: Berenberg upgrades from hold to buy with a target price of 750p.Rexam: Deutsche Bank ups target price from 550p to 570p, while downgrading from buy to hold.Ricardo: Oriel places both its target price (prev.: 670p) and its reduce rating under review.Rio Tinto: Goldman Sachs lowers target price from 2530p to 2520p reiterating its strong sell recommendation. JP Morgan ups target price from 4100p to 4150p and stays with its overweight rating. Canaccord Genuity cuts target price from 4200p to 4145p and reiterates a buy recommendation.Royal Mail: Deutsche Bank reduces target price from 587p to 486p and retains a hold recommendation. JP Morgan cuts target price from 765p to 745p and stays with an overweight rating.Thomas Cook Group: Numis reduces target price from 175p to 135p and maintains its hold recommendation.Trinity Exploration & Production: Investec places its target price (prev.: 250p) under review, while keeping a buy recommendation.Tullow Oil: Canaccord Genuity reduces target price from 950p to 850p and stays with its hold recommendation.Weatherly International: Canaccord Genuity lowers target price from 6p to 5p and keeps its buy recommendation.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.